Daptomycin plus fosfomycin provided a 12% higher rate of treatment success than daptomycin alone, but this difference did not reach statistical significance and it was more often associated with adverse events.
← all excerpts
What happened to infectious diseases and anti-infective therapy in 2020 beyond COVID-19?
1
—
—